Market Exclusive

Analyst Activity – Bank of America Initiates Coverage On Nabriva Therapeutics (NASDAQ:NBRV) With a Buy

Analyst Ratings For Nabriva Therapeutics (NASDAQ:NBRV)

Today, Bank of America initiated coverage on Nabriva Therapeutics (NASDAQ:NBRV) with a Buy with a price target of $10.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Nabriva Therapeutics (NASDAQ:NBRV)
Nabriva Therapeutics (NASDAQ:NBRV) has insider ownership of 2.75% and institutional ownership of 55.59%.

Recent Trading Activity for Nabriva Therapeutics (NASDAQ:NBRV)
Shares of Nabriva Therapeutics closed the previous trading session at 5.66 up +0.27 4.92% with 5.599999904632568 shares trading hands.

Exit mobile version